Aplastic anemia diagnostic study of choice
|
Aplastic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Aplastic anemia diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Aplastic anemia diagnostic study of choice |
|
Risk calculators and risk factors for Aplastic anemia diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Nazia Fuad M.D.
Overview
The bone marrow biopsy is the gold standard test for the diagnosis of aplastic anemia. A hematopathologist will review the bone marrow biopsy findings, and confirmatory results for aplastic anemia include hypoplasia with <20% cellularity, normal maturation of all cell lines, presence of fat cells and stroma in bone marrow space. Residual hematopoietic cells are morphologically normal. Hematopoiesis is not megaloblastic.
Diagnostic Study of Choice
Study of choice
The bone marrow biopsy is the gold standard test for the diagnosis of aplastic anemia[1]
Diagnostic results
The following findings on performing bone marrow biopsy are confirmatory for aplastic anemia:
- Hypoplasia with <20% cellularity
- Normal maturation of all cell lines
- Presence of adipose cells and stroma in bone marrow space
- Presence of morphologically normal residual hematopoietic cells
- Absence of megaloblastic hematopoiesis
Sequence of diagnostic studies
- In adults with aplastic anemia, these tests should be done to detect coexistent disorders, such as paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, or acute leukemia[2]:
- Flow cytometry for assessment of cell surface CD59 on peripheral blood red blood cells or neutrophils.
- Cytogenetic and molecular testing of bone marrow
- Hemoglobin electrophoresis and blood-group testing
- Serology
- Fluorescence-activated cell sorter (FACS) profiling
- Fluorescent-labeled inactive toxin aerolysin (FLAER) testing
- Diepoxybutane incubation
- Histocompatibility testing
- In children with aplastic anemia, genetic testing should be performed to find out inherited genetic abnormalities.
References
- ↑ Dezern AE, Brodsky RA (April 2011). "Clinical management of aplastic anemia". Expert Rev Hematol. 4 (2): 221–30. doi:10.1586/ehm.11.11. PMC 3138728. PMID 21495931.
- ↑ D'Andrea AD, Grompe M (January 2003). "The Fanconi anaemia/BRCA pathway". Nat. Rev. Cancer. 3 (1): 23–34. doi:10.1038/nrc970. PMID 12509764.